<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(1)</volume><submitter>Zhang D</submitter><pubmed_abstract>Pyruvate kinase M1 (PKM1) is a critical enzyme in glycolysis, particularly in high-energy-demand tissues like the heart. However, previous knockout strategies for PKM1 were confounded by compensatory upregulation of its low-activity splice variant, PKM2. Here, we generated a &lt;i>Pkm1&lt;/i> mutant mouse model using a point mutation that eliminates PKM1 without compensatory PKM2 upregulation. Homozygous &lt;i>Pkm1&lt;/i> mutants exhibited perinatal lethality associated with cardiac dysfunction, characterized by thin myocardium and reduced cardiomyocyte proliferation during mid-to-late gestation. We found that PKM1 sustains ATP levels to inhibit AMPK, which otherwise promotes NFYa phosphorylation and destabilization. NFYa, a transcription factor essential for cardiomyocyte proliferation, has been iden</pubmed_abstract><journal>National science review</journal><pagination>nwaf408</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12796809</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>PKM1 is required for embryonic cardiomyocyte proliferation through energetic regulation of NFYa stability.</pubmed_title><pmcid>PMC12796809</pmcid><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Zhang D</pubmed_authors><pubmed_authors>Xu D</pubmed_authors><pubmed_authors>Ye W</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Yang D</pubmed_authors><pubmed_authors>Huang R</pubmed_authors><pubmed_authors>Zhao Y</pubmed_authors><pubmed_authors>Qin S</pubmed_authors><pubmed_authors>Su N</pubmed_authors><pubmed_authors>Shi G</pubmed_authors><pubmed_authors>Kou X</pubmed_authors><pubmed_authors>Tang Y</pubmed_authors><pubmed_authors>Gao S</pubmed_authors><pubmed_authors>Kang L</pubmed_authors><pubmed_authors>Wei K</pubmed_authors></additional><is_claimable>false</is_claimable><name>PKM1 is required for embryonic cardiomyocyte proliferation through energetic regulation of NFYa stability.</name><description>Pyruvate kinase M1 (PKM1) is a critical enzyme in glycolysis, particularly in high-energy-demand tissues like the heart. However, previous knockout strategies for PKM1 were confounded by compensatory upregulation of its low-activity splice variant, PKM2. Here, we generated a &lt;i>Pkm1&lt;/i> mutant mouse model using a point mutation that eliminates PKM1 without compensatory PKM2 upregulation. Homozygous &lt;i>Pkm1&lt;/i> mutants exhibited perinatal lethality associated with cardiac dysfunction, characterized by thin myocardium and reduced cardiomyocyte proliferation during mid-to-late gestation. We found that PKM1 sustains ATP levels to inhibit AMPK, which otherwise promotes NFYa phosphorylation and destabilization. NFYa, a transcription factor essential for cardiomyocyte proliferation, has been iden</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-06-03T03:15:04.53Z</modification><creation>2026-06-03T03:10:39.164Z</creation></dates><accession>S-EPMC12796809</accession><cross_references><pubmed>41536305</pubmed><doi>10.1093/nsr/nwaf408</doi></cross_references></HashMap>